DEFB115
gene geneOn this page
Also known as DEFB-15
Summary
DEFB115 (defensin beta 115, HGNC:18096) is a protein-coding gene on chromosome 20q11.21, encoding Beta-defensin 115 (Q30KQ5). Has antibacterial activity.
Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions.
Source: NCBI Gene 245929 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_001037730
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18096 |
| Approved symbol | DEFB115 |
| Name | defensin beta 115 |
| Location | 20q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-15 |
| Ensembl gene | ENSG00000215547 |
| Ensembl biotype | protein_coding |
| Entrez | 245929 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000400552
RefSeq mRNA: 1 — MANE Select: NM_001037730
NM_001037730
CCDS: CCDS42859
Canonical transcript exons
ENST00000400552 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001543455 | 31259460 | 31259632 |
| ENSE00001543456 | 31257664 | 31257757 |
Expression profiles
Bgee: expression breadth broad, 26 present calls, max score 37.20.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| monocyte | CL:0000576 | 29.33 | gold quality |
| leukocyte | CL:0000738 | 29.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.19 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 24.99 | silver quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| frontal cortex | UBERON:0001870 | 24.13 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 23.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 23.79 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The encoded protein is thought to display antimicrobial activity. (PMID:16033865)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb28 | ENSMUSG00000074679 |
| rattus_norvegicus | Defb28 | ENSRNOG00000036900 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 115 — Q30KQ5 (reviewed: Q30KQ5)
Alternative names: Beta-defensin 15, Defensin, beta 115
All UniProt accessions (1): Q30KQ5
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001032819* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
| IPR050544 | Beta-defensin | Family |
Pfam: PF13841
UniProt features (5 total): disulfide bond 3, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q30KQ5-F1 | 74.46 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 38–65, 45–59, 49–66
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 13 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, chr20q11, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_CELL_KILLING, GOBP_RESPONSE_TO_BACTERIUM, REACTOME_ANTIMICROBIAL_PEPTIDES, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM, GOMF_MEMBRANE_DESTABILIZING_ACTIVITY, REACTOME_DEFENSINS, REACTOME_BETA_DEFENSINS
GO Biological Process (4): innate immune response (GO:0045087), defense response to Gram-negative bacterium (GO:0050829), defense response (GO:0006952), defense response to bacterium (GO:0042742)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| immune response | 1 |
| defense response to symbiont | 1 |
| defense response to bacterium | 1 |
| response to stress | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
224 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB115 | DEFB127 | Q9H1M4 | 643 |
| DEFB115 | DEFB116 | Q30KQ4 | 632 |
| DEFB115 | DEFB121 | Q5J5C9 | 621 |
| DEFB115 | DEFB118 | Q96PH6 | 611 |
| DEFB115 | DEFB123 | Q8N688 | 585 |
| DEFB115 | DEFB110 | Q30KQ9 | 574 |
| DEFB115 | ZNF727 | A8MUV8 | 507 |
| DEFB115 | BPIFC | Q8NFQ6 | 492 |
| DEFB115 | GLB1L2 | Q8IW92 | 481 |
| DEFB115 | DEFB114 | Q30KQ6 | 480 |
| DEFB115 | DEFB126 | Q9BYW3 | 479 |
| DEFB115 | WFDC12 | Q8WWY7 | 478 |
| DEFB115 | DEFB113 | Q30KQ7 | 470 |
| DEFB115 | DEFB128 | Q7Z7B8 | 459 |
| DEFB115 | PGLYRP3 | Q96LB9 | 445 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBQLN1 | DEFB115 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB115 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB115 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB115 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): DEFB115 (Two-hybrid), DEFB115 (Two-hybrid)
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H225, A4H227, A4H228, A4H238, A4H240, A4H253, A4H254, A4H255, A4H257, A4H258, A4H259, A4H262, A4H263, A4H264, A4H265, P0C8A8, P0DY26, P0DY27, Q29RT9, Q30KJ7, Q30KK0, Q30KK1, Q30KK9, Q30KL1, Q30KL7, Q30KP3, Q30KP5, Q30KQ4, Q30KQ5, Q30KQ8, Q30KR1, Q30KT5, Q32P86, Q32ZH2, Q32ZH6, Q3UW43
Diamond homologs: A4H220, A4H221, A4H222, A4H223, P0C8A5, Q30KK6, Q30KK9, Q30KQ5, Q5J5C9, Q95LI0, Q96PH6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 17 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
145 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:31259454:TGATA:T | acceptor_loss | 0.9800 |
| 20:31259457:TAG:T | acceptor_loss | 0.9800 |
| 20:31259459:G:GA | acceptor_loss | 0.9800 |
| 20:31259454:T:TA | acceptor_gain | 0.9700 |
| 20:31259458:A:AG | acceptor_gain | 0.9700 |
| 20:31259458:AGAT:A | acceptor_gain | 0.9700 |
| 20:31259458:AGATG:A | acceptor_gain | 0.9700 |
| 20:31259459:G:GG | acceptor_gain | 0.9700 |
| 20:31259459:GATG:G | acceptor_gain | 0.9700 |
| 20:31259459:GATGG:G | acceptor_gain | 0.9700 |
| 20:31259459:GAT:G | acceptor_gain | 0.9500 |
| 20:31257753:CCCAG:C | donor_loss | 0.9300 |
| 20:31257754:CCAG:C | donor_loss | 0.9300 |
| 20:31257755:CAG:C | donor_loss | 0.9300 |
| 20:31257756:AG:A | donor_loss | 0.9300 |
| 20:31257757:GG:G | donor_loss | 0.9300 |
| 20:31257758:GTAA:G | donor_loss | 0.9300 |
| 20:31257759:T:G | donor_loss | 0.9300 |
| 20:31257788:G:GT | donor_gain | 0.9200 |
| 20:31257787:GGGA:G | donor_gain | 0.8700 |
| 20:31258559:T:A | donor_gain | 0.8600 |
| 20:31259459:GA:G | acceptor_gain | 0.8400 |
| 20:31258375:G:GA | donor_gain | 0.8200 |
| 20:31258374:T:TA | donor_gain | 0.7900 |
| 20:31258561:T:G | donor_gain | 0.7900 |
| 20:31259450:ATTTT:A | acceptor_gain | 0.7800 |
| 20:31257760:A:C | donor_loss | 0.7600 |
| 20:31258560:A:AG | donor_gain | 0.7600 |
| 20:31258380:A:G | donor_gain | 0.7400 |
| 20:31258462:G:A | acceptor_gain | 0.7400 |
AlphaMissense
563 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:31259477:T:A | C38S | 0.972 |
| 20:31259478:G:C | C38S | 0.972 |
| 20:31259540:T:A | C59S | 0.967 |
| 20:31259541:G:C | C59S | 0.967 |
| 20:31259498:T:A | C45S | 0.964 |
| 20:31259499:G:C | C45S | 0.964 |
| 20:31259558:T:A | C65S | 0.957 |
| 20:31259559:G:C | C65S | 0.957 |
| 20:31259561:T:A | C66S | 0.957 |
| 20:31259562:G:C | C66S | 0.957 |
| 20:31259493:G:A | G43D | 0.956 |
| 20:31259492:G:T | G43C | 0.953 |
| 20:31259503:G:C | R46S | 0.951 |
| 20:31259503:G:T | R46S | 0.951 |
| 20:31259477:T:C | C38R | 0.947 |
| 20:31259510:T:A | C49S | 0.944 |
| 20:31259511:G:C | C49S | 0.944 |
| 20:31259479:C:G | C38W | 0.943 |
| 20:31259560:C:G | C65W | 0.941 |
| 20:31259558:T:C | C65R | 0.940 |
| 20:31259478:G:A | C38Y | 0.935 |
| 20:31259540:T:C | C59R | 0.935 |
| 20:31259498:T:C | C45R | 0.930 |
| 20:31259559:G:A | C65Y | 0.929 |
| 20:31259500:C:G | C45W | 0.927 |
| 20:31259561:T:C | C66R | 0.921 |
| 20:31259524:G:C | E53D | 0.917 |
| 20:31259524:G:T | E53D | 0.917 |
| 20:31259493:G:T | G43V | 0.916 |
| 20:31259502:G:T | R46M | 0.916 |
dbSNP variants (sampled 300 via entrez): RS1000107068 (20:31255823 C>T), RS1000209091 (20:31259437 C>A,T), RS1001513599 (20:31257860 G>A,T), RS1002055837 (20:31258036 T>C), RS1002303902 (20:31258859 G>C), RS1003710642 (20:31255703 G>A,T), RS1003741755 (20:31255836 C>T), RS1003764456 (20:31258935 T>C), RS1003937565 (20:31259689 C>G,T), RS1003956227 (20:31258011 G>A,T), RS1004078674 (20:31256721 G>A,T), RS1005658636 (20:31258913 A>G), RS1005744998 (20:31257600 G>A), RS1006101605 (20:31258166 C>T), RS1006788102 (20:31256543 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004639_6 | Prudent dietary pattern | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Acetaminophen | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.